Favipiravir: A new and emerging antiviral option in COVID-19
Umang Agrawal, Reyma Sara Raju, Zarir Udwadia
Topics & Concepts
FavipiravirMedicineCoronavirus disease 2019 (COVID-19)Context (archaeology)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusAntiviral drugVirologyIntensive care medicineDrugGlobeDrug approvalDiseasePharmacologyOutbreakInfectious disease (medical specialty)PathologyPaleontologyOphthalmologyBiologyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchInfluenza Virus Research Studies